The American Hospital Association (AHA) and the Association for Advancement of Medical Instrumentation (AAMI) brought together a small group composed of hospital and health system leaders, device ...

Scientists have revealed how tiny swimming organisms—such as bacteria—are able to move faster when traveling as a group—and ...

The field is evolving—don’t get left behind. Expand your network and join 80+ structural biologists, medicinal chemists, ...

G Protein-Coupled Receptors (GPCRs) in advancing GPCR-targeted therapies, including the use of agonists, antagonists, biased ...

LTRN READ THE FULL LTRN RESEARCH REPORT Lantern Pharma, Inc (NASDAQ:LTRN) reports 2024 results highlighting several ...

Generative Phosphoproteomics AP3 platform designed to enable streamlined, rational drug discovery, with proprietary, proteome-wide SAR delivering ...

Kyverna Therapeutics, Inc. (Nasdaq: KYTX), a clinical-stage biopharmaceutical company focused on developing cell therapies for patients with autoimmune diseases, today reported its business highlights ...

Certain widely used drug combinations may either slow down or worsen the progression of Alzheimer's disease, but their ...

Everyone loves Jordan shoes and sneakers, but not everyone loves paying well over $100 for each pair of them. The focus for ...

Mohanlal and Prithviraj’s heavy-handed symbolism and weak writing fail to elevate it beyond a lackluster sequel to Lucifer.

Scientists have made a potentially “life-changing” discovery that could pave the way for new drugs to treat Parkinson’s disease. Experts have known for several decades that the PINK1 protein ...